Effect of rimonabant on weight reduction and cardiovascular risk.
Astrup
Arne
A
D001794:Blood Pressure / Q000187:drug effects*; D063387:Cannabinoid Receptor Antagonists; D002318:Cardiovascular Diseases / Q000209:etiology; D002784:Cholesterol / Q000097:blood*; D006801:Humans; D009765:Obesity / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D010880:Piperidines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D000077285:Rimonabant; D012307:Risk Factors; D015431:Weight Loss
D063387:Cannabinoid Receptor Antagonists; D010880:Piperidines; D011720:Pyrazoles; D002784:Cholesterol; D000077285:Rimonabant